Sign in

CIK 0001429260

  • Non-accelerated filer
  • Smaller reporting company

Fortress Biotech, Inc.

Sign in to watch
Ticker
FBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205157386
Phone
+1 781-652-4500
Business address
1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
Former names
Fortress Biotech, Inc., CORONADO BIOSCIENCES INC

Securities

  • FBIO Common Stock Nasdaq
  • FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 47 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-01-01 Harvey Jimmie Director Grant or award · Deferred Restricted Stock Units +16,666 33,332
2017-01-01 Harvey Jimmie Director Grant or award · Deferred Restricted Stock Units +16,666 33,332
2016-12-01 ROSENWALD LINDSAY A MD President and CEO Purchase +731 $2.03 $1K 5,304,470
2016-09-16 Avgerinos George SVP, Biologics Operations Sale −33,912 $2.55 $86K 259,088
2016-09-15 Avgerinos George SVP, Biologics Operations Sale −15,000 $2.54 $38K 293,000
2016-09-14 Avgerinos George SVP, Biologics Operations Grant or award +150,000 308,000
2016-07-15 Klein Dov Director Returned to the company −13,333 141,667
2016-07-15 Klein Dov Director Grant or award · Deferred Restricted Stock Units +13,333 13,333
2016-06-01 ROSENWALD LINDSAY A MD President and CEO Purchase +613 $2.40 $1K 5,303,739
2016-03-14 Harvey Jimmie Director Grant or award · Deferred Restricted Stock Units +16,666 16,666
2016-03-14 Harvey Jimmie Director Grant or award · Deferred Restricted Stock Units +16,666 16,666
2016-03-14 Hoenlein Malcolm Director Grant or award · Deferred Restricted Stock Units +16,666 16,666
2016-01-01 ROSENWALD LINDSAY A MD President and CEO Grant or award +510,434 5,303,126
2016-01-01 WEISS MICHAEL S Exec. VC - Strategic Dev. Grant or award +510,434 7,448,472
2016-01-01 LOBELL J JAY Director Grant or award +100,000 586,000
2016-01-01 Rowinsky Eric K Director Grant or award +100,000 250,000
2016-01-01 Klein Dov Director Grant or award +100,000 155,000
2015-12-01 ROSENWALD LINDSAY A MD President and CEO Purchase +586 $2.41 $1K 4,792,692
2015-09-11 Avgerinos George SVP, Biologics Operations Returned to the company −31,299 $2.68 $84K 158,000
2015-09-10 Avgerinos George SVP, Biologics Operations Returned to the company −22,737 $2.62 $60K 189,299

Page 9 of 12 · 231 trades